Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Other Non Operating Income (2016 - 2025)

Dare Bioscience's Other Non Operating Income history spans 10 years, with the latest figure at -$276570.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 114.99% year-over-year to -$276570.0; the TTM value through Dec 2025 reached -$153060.0, down 115.59%, while the annual FY2025 figure was -$153060.0, 115.59% down from the prior year.
  • Other Non Operating Income reached -$276570.0 in Q4 2025 per DARE's latest filing, down from $109382.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.8 million in Q4 2024 to a low of -$732883.0 in Q1 2024.
  • Average Other Non Operating Income over 5 years is $113602.6, with a median of $63497.5 recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: soared 59200.0% in 2022, then tumbled 315.46% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $175.0 in 2021, then soared by 164096.57% to $287344.0 in 2022, then crashed by 60.36% to $113898.0 in 2023, then surged by 1519.68% to $1.8 million in 2024, then tumbled by 114.99% to -$276570.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Other Non Operating Income are -$276570.0 (Q4 2025), $109382.0 (Q3 2025), and -$188683.0 (Q2 2025).